Pain and Inflammation
chronic inflammatory diseases - such as Sickle Cell Disease,
Osteoarthritis, cancer and dementias - through transdermal
drug loading of circulating blood cells for targeted
delivery within the vasculature.
Innovating treatments for chronic diseases via transdermal loading of drugs into circulating blood cells for targeted anti-inflammatory activity
Vascarta is a clinical-stage pharmaceutical company built on three core assets designed to increase therapeutic effectiveness while improving the patient experience.
Leading areas of study are Sickle Cell disease, Osteoarthritis, Dementia, and Cancer.
Vasporta™ Transdermal Delivery
OUR LEAD PRODUCT
CANDIDATE: VAS-101
Targeted
Cancer
Therapeutics
OUR LEAD PRODUCT CANDIDATE: VAS101
Why Vascarta? Four Pillars of Innovation
Vasporta™ Technology:
Advanced transdermal delivery platform designed to improve absorption, eliminate the need for injections, and overcome oral bioavailability limitations.
Vasceptor® Formulation:
Next-generation curcumin-based therapy demonstrating enhanced absorption, deep skin penetration, and systemic therapeutic potential through red blood cell distribution.Oncology Licensing Platform:
Exclusive rights to CUNY’s novel linker chemistry, enhancing cancer drug efficacy while reducing side effects through targeted curcumin conjugation.Broad Therapeutic Potential:
Applicable across multiple health areas including Sickle Cell Disease, Osteoarthritis, Hypertension, Aging, Brain Cancer, and Pancreatic Cancer.
Research and Clinical Trials
Safety
Extensive scientific studies confirm curcumin gel’s safety for topical application with no reported adverse effects.
Pre-Clinical Validation
Comprehensive pre-clinical studies highlight curcumin gel’s potential in addressing endothelial dysfunction.
Treatments with Curcumin-Gel
Innovative formulations show enhanced curcumin absorption, improving red blood cell health and stability.
Results
Results indicate measurable improvement in inflammation, oxidative stress, and vascular health markers.
Animal Research
Animal models demonstrate significant anti-inflammatory and wound-healing properties of curcumin gel.
Other Effectiveness Studies
Additional studies validate curcumin gel’s efficacy in diverse applications, including pain and skin repair.
Hear From Our Founder: Revolutionizing Healthcare Through Innovation
Vascarta is a clinical stage pharmaceutical company exploring the enhancement of proven medications via transdermal delivery or linker technology. Our patented technologies overcome the limitations of existing delivery systems to safely and effectively achieve therapeutic concentrations in target tissues, with fewer off-target effects. We have assembled an experienced team of industry experts in research, formulation, development committed to advancing our organization from exploration to commercialization.
Dr. Richard Prince, PhD
Chairman of the Board, CEO & President
Dr. Joel Friedman, MD PhD
Chief Scientific Officer, Board member
Travis Gering, JD
Executive Vice President Corporate Development, Board member
Henry Miller
Executive Vice President, Commercialization
Paul Sklar
ConsultantWhat People Are Saying
Substantially eased the pain in my arthritic left knee. Minimal problems now going up or down stairs.
Stopped pain due to severe knee osteoarthritis to the extent that I could resume playing basketball and practice martial arts.
I used it last week for a painful gum sore – pain gone within 6 hr.
Enhanced performance endurance (from 30 minutes to over an hour) for intense non-stop drumming.
Thank you for the opportunity to try the medication. It definitely helped my hip pain. I need hip replacements. It made me feel good enough that I undertook a 3-mile walk. The hips are just too far gone to do that without pain, however. It has been nice to feel good if only for a short time.
Put on medial knee fat pad, pain in medial knee from swim accident. Put on at 8 am. No sharp pain in my knee all day until that night. Typically, I have pain intermittently all day long. I was awed!
Join Us to Revolutionize Healthcare with Scalable Solutions
